Why Small Biotech Stocks Top List of Potential Outperformers this Fall (GTHX, ATRX, SRPT, MGNX, CPRX, CLDX, BDSI, SAVA)

The smaller cap biotech space offers two key advantages for investors right now: cyclical diversification and diversification away from the vaccine monolithic theme. To break that down a bit, the stock market has been volatile over the past month, with many growth plays getting smacked down as risk comes off the table with Wall Street […]

Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX): DMC Approves Phase III Study Of Firdapse

Boston, MA 10/22/2013 (wallstreetpr) – After the Data Monitoring Committee (DMC) approval, Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) will now continue with the pivotal phase III clinical trial of Firdapse in the U.S. and Europe. This drug is geared towards the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS). This follows DMC’s clinical data and safety reviews on the drug. […]